Presented: European Congress of Pathology 2023
Study objective: To assess a clinically deployed artificial intelligence (AI) decision support solution for prostate biopsies, which was previously validated at UPMC1, in primary diagnosis employed in a digital pathology workflow.
- Successful implementation of a multi-feature AI solution that automatically imparts clinically relevant diagnostic parameters regarding prostate cancer, grading, measurements, and other pathologic features at UPMC
- The solution demonstrated high accuracy for prostate cancer detection and improved diagnostic quality
- All pathologists feel confident in providing accurate diagnoses when reporting slides supported by Galen Prostate
- In the near future, AI and Digital Pathology will enable UPMC to implement a Centralized Laboratory approach
Click here to download the study:Back